In addition, we tested whether CCI-006 synergized with the DOT1L inhibitor EPZ-5676 (Pinometostat) that showed modest clinical efficacy in adult patients with advanced acute leukemias, including MLL-r leukemias [5, 13, 16]. Here, KMT2A is linked to acute leukemia.